Recipharm's financial objectives
Recipharm’s objective is to be a world leading supplier of CDMO services.
The financial objectives are:
- Compound Annual Growth Rate (CAGR) of at least 11%, with 2019 as base year. The growth will be organic as well as come from acquisitions
- EBITA margin of at least 12% each year, measured as profit before financial items, tax and amortisation of intangible assets attributable to acquisitions, adjusted for non-recurring items and in relation to net sales
- A return on operating capital of 10%, defined as EBITA divided by operating capital